Time to Positive Blood Cultures Among Critically Ill Children Admitted to the PICU

Stephanie M Yasechko1, Margot M Hillyer2, Alison G C Smith3

  • 1Division of Pharmacy, Cincinnati Children's Hospital Medical Center, Cincinnati, OH.

PubMed

Insights

In critically ill children, 95% of significant blood cultures turned positive within 36 hours, irrespective of immune status. This suggests reassessing antimicrobial therapy and considering shorter empiric antibiotic durations for low-risk patients.

Area of Science:

  • Pediatric critical care medicine
  • Infectious diseases
  • Clinical microbiology

Background:

  • Bloodstream infections are a significant concern in critically ill children.
  • Timely detection of bacteremia is crucial for effective treatment and patient outcomes.
  • Understanding the time to positivity (TTP) of blood cultures can inform diagnostic and therapeutic strategies.

Purpose of the Study:

  • To evaluate the time to positivity (TTP) for clinically significant blood cultures in pediatric intensive care unit (PICU) patients.
  • To analyze factors influencing TTP, including pathogen type and host immune status.

Main Methods:

  • A retrospective review of positive blood cultures from patients aged 0-20 years admitted to a large tertiary-care PICU.
  • Analysis of TTP, defined as time from blood culture draw to initial Gram stain result.
  • Stratification of TTP by host immune status (previously healthy, standard risk, immunocompromised).

Main Results:

  • The median TTP for 164 episodes of bacteremia was 13.3 hours.
  • By 36 hours, 95% of positive blood cultures yielded results.
  • Median TTP varied by immune status (10.6 hours for immunocompromised vs. 13.2-14.0 hours for others; p=0.001), but was independent of blood volume or Gram stain type.

Conclusions:

  • A high percentage (95%) of clinically significant blood cultures in critically ill children yield positive results within 36 hours.
  • Findings support frequent reassessment of antimicrobial therapy needs.
  • Consideration of shorter empiric antibiotic durations in low-suspicion cases is warranted.
Abstract

Related Concept Videos

Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
317
Sputum Studies II: Culture and Sensitivity01:20

Sputum Studies II: Culture and Sensitivity

Description
Sputum culture and sensitivity is a medical procedure used to diagnose bacterial infections in the respiratory tract and select the most appropriate antibiotics for treatment. This process involves analyzing sputum samples of thick and opaque secretions produced in the lungs and airways. These samples are collected from patients and then sent to the laboratory for analysis.
The test can identify various pathogens responsible for respiratory infections, including Streptococcus,...
292
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
198
Parentral Nutrition: Centeral and Peripheral Parental Nutrition01:27

Parentral Nutrition: Centeral and Peripheral Parental Nutrition

Parenteral Nutrition (PN) delivers essential nutrients directly into the bloodstream, bypassing the digestive system. It is commonly used for individuals with severe digestive disorders or conditions that prevent normal nutrient absorption.
PN can be administered through two primary routes:
1. Central Parenteral Nutrition (CPN):
CPN involves delivering a high concentration of nutrients through a large vein. This is typically achieved using a Peripherally Inserted Central Catheter (PICC) or,...
123
Transmission-based Precautions II: Airborne and Protective Environment01:25

Transmission-based Precautions II: Airborne and Protective Environment

Transmission-based precautions are for patients infected or suspected to be infected (or colonized) with organisms posing a significant risk to others. The transmission precautions include airborne and protective environment precautions.
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...
1.2K